MindImmune Therapeutics, Inc.
New Filing
CIK: 0001792522·Pharmaceuticals·DELAWARE·Filed: Feb 4, 2022
Total Offering
$8,880,000
Amount Sold
$5,349,999
Investors
12
First Sale
Jan 25, 2022
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Stevin Zorn | Related Person |
| Christopher O'Donnell | Related Person |
| Tracy Saxton | Related Person |
| Diane Gooding | Related Person |
| Robert B. Nelson | Related Person |
Company
SEC Filing
0000908662-22-000006
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free